Mounjaro injection points: where to inject and why rotation matters

You've picked up your pen for the first time, where does the needle actually go?

Picture this: pen in hand, a quiet moment, and the leaflet open in front of you. The three approved injection sites are the abdomen (the soft, pinchable area around the navel, staying at least 5 cm away from the navel itself), the front or outer part of the thigh, and the outer upper arm. That's it. Anywhere else on the body is outside the licensed sites, and the absorption evidence doesn't extend there.

The abdomen tends to be the easiest site for most people because it's easy to see, easy to reach, and offers a generous area of subcutaneous tissue. The thigh works well if you prefer to sit with the leg relaxed and flat on a surface. The upper arm requires a second person or a degree of flexibility, pressing the pen firmly against a wall or chair can help but injecting into the abdomen or thigh is simpler when you're alone. Read through the full injection technique guide for a step-by-step walkthrough of preparing and giving the Mounjaro injection, from start to finish.

One practical detail: many people keep their pen in the fridge door between doses, which is fine as long as the temperature stays between 2°C and 8°C. Before injecting, let the pen sit at room temperature for roughly 30 minutes, it makes the injection more comfortable. For the exact room-temperature window and storage rules, the Mounjaro SmPC on the eMC is the authoritative source.

Why rotating your injection points matters more than people expect

Injecting into exactly the same spot week after week causes cumulative trauma to the subcutaneous fat. The tissue can develop lipodystrophy (areas of hardening, lumping or hollowing) and once that happens, absorption from that patch becomes erratic. Tirzepatide is absorbed differently through altered fat tissue, which can affect how consistently the medicine works.

The solution is systematic rotation. Within whichever site you use, move the needle placement at least 1–2 cm from the previous injection each week. A common approach is to work around the abdomen like a clock face, keeping track of where you were. If you alternate between sites week to week (abdomen one week, thigh the next) you give each area even longer to recover.

You can use different sites on different weeks, but avoid switching on the same day as a dose change or when troubleshooting an unusually sore spot; stick with a familiar, comfortable site while things settle. If you notice a lump, hard patch or skin discolouration at any injection site, move away from it and mention it at your next clinical review. The injection site detail page covers what normal post-injection skin looks like versus what warrants attention.

Cleaning the skin with an alcohol swab before injecting and letting it dry fully is good practice. If you go through needles regularly, alcohol swabs are available from our pharmacy so you're never without them.

Does it matter which site you choose each week?

In short: all three sites are clinically appropriate, and the differences in absorption between them are modest. What matters far more is that you rotate consistently within and between sites, avoid damaged skin, and inject subcutaneously rather than into muscle or too close to the surface. A good injection goes into the layer of fat beneath the skin; pinching the skin gently before pressing the pen helps if you're lean or injecting into the thigh.

Some people wonder whether choosing a different site affects how quickly Mounjaro acts or whether side effects vary by location. The evidence doesn't support meaningfully different onset or efficacy by site, though individual comfort does vary. If nausea after a dose is bothering you, the site choice isn't the lever to pull, the wider Mounjaro injections page covers managing common side effects alongside technique. The NHS's patient information on tirzepatide also addresses what to expect and when to seek help.

For people asking whether there's a meaningful advantage to one site over another, there's a dedicated answer on the does injection site matter for Mounjaro page, which goes deeper into the pharmacokinetic evidence, including how the design of the Mounjaro injection pens interacts with site selection.

When to get medical help, and what to mention to your prescriber

Most injection-site reactions are mild: slight redness, itching or a small welt that clears within 24–48 hours. These don't usually require any action beyond rotating your next injection point away from that spot.

Seek prompt medical attention if you develop a reaction that spreads, worsens over a day, shows signs of infection (warmth, swelling, pus), or if you experience a more generalised allergic response such as swelling of the face, lips or throat, difficulty breathing, or a rash across the body. These are rare but serious. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets you report any suspected side effect, whether injection-related or systemic, and doing so genuinely helps build the post-market safety picture for this medicine.

At every repeat order, a prescriber at nume reviews your progress, this is the right moment to flag any persistent site problems, skin changes, or questions about rotating technique. If something comes up between reviews, the aftercare team can triage it. Mounjaro is a prescription-only treatment, and questions about your individual technique or site concerns are best resolved with your own clinician rather than generic advice. If you haven't started yet and are exploring your options, start your free consultation to have your suitability assessed by one of our GPhC-registered prescribers.